DCPH
HEALTHCAREDeciphera Pharmaceuticals Inc
—PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving DCPH Today?
No stock-specific AI insight has been generated for DCPH yet. Check back soon — insights are generated from recent news analysis.
0
Fundamentals
Market Cap$2.2B
P/E Ratio—
EPS$-2.21
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-1.1%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding86.5M
DCPH News
No news articles found for DCPH yet.
Price Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High$0.00
52 Week Low$0.00
Fundamentals
Market Cap$2.2B
P/E Ratio—
EPS$-2.21
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-1.1%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding86.5M
About Deciphera Pharmaceuticals Inc
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to improve the lives of cancer patients by addressing key drug resistance mechanisms that limit the rate and durability of response to existing cancer therapies. The company is headquartered in Waltham, Massachusetts.
Listed September 28, 2017
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—